The most common mechanism of activation of TGFβ signaling in CRC is due to mutations in transforming growth factor β receptor type 2 (TGFβR2), which occurs in approximately 30% of CRC cases [182]. The gene discussed is TGFB1; the disease is colorectal carcinoma.